Quell Therapeutics Advances QEL-001, Its Multi-Modular Engineered CAR-Treg Cell Therapy, Into Efficacy Cohort Of LIBERATE Phase 1/2 Trial In Liver Tra...
Progress in the LIBERATE trial was presented at the American Transplant
Source: menafn.com
Mark Swallow News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Mark Swallow. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Mark Swallow Today - Breaking & Trending Today
Nouscom Raises €67.5 million ($72 million) in
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of its...
Source: globenewswire.com
Nouscom Raises €67.5 million ($72 million) in Oversubscribed Series C Financing Round
New specialist European and US life sciences investors join existing investors to enable Nouscom to continue advancing the clinical development of...
Source: businessinsider.com
Nouscom's Off-the-Shelf Cancer Vaccine, NOUS-209, Shows Potential to 'Intercept' Cancer in Subjects with Lynch Syndrome
Lynch Syndrome is a common hereditary condition associated with a genetic predisposition to and high-risk of developing colorectal and other cance...
Source: businessinsider.com
Nordic Nanovector ASA announces that Ludvik Sandnes has been appointed interim Chief Executive Officer (CEO) and Chief F
OSLO, Norway, Feb. 1, 2023 /PRNewswire/ -- Nordic Nanovector ASA ("Nordic Nanovector" or the "Company")...
Source: europapress.es